Literature DB >> 22815329

Cardiovascular drugs and cancer: of competing risk, smallpox, Bernoulli, and d'Alembert.

Franz H Messerli1, Sripal Bangalore, Christian Torp-Pedersen, Jan A Staessen, John B Kostis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815329     DOI: 10.1093/eurheartj/ehs158

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Angiotensin receptor blockers: are they related to lung cancer?

Authors:  Gowtham Adamane Rao; Joshua R Mann; Azza Shoaibi; Sachin G Pai; Matteo Bottai; Shawn Scott Sutton; Kathlyn Sue Haddock; Charles Lee Bennett; James R Hebert
Journal:  J Hypertens       Date:  2013-08       Impact factor: 4.844

2.  Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.

Authors:  Matthew T Roe; Derek D Cyr; Debra Eckart; Phillip J Schulte; Michael A Morse; Kimberly L Blackwell; Neal E Ready; S Yousuf Zafar; Anne W Beaven; John H Strickler; Jane E Onken; Kenneth J Winters; Lisa Houterloot; Dmitry Zamoryakhin; Stephen D Wiviott; Harvey D White; Dorairaj Prabhakaran; Keith A A Fox; Paul W Armstrong; E Magnus Ohman
Journal:  Eur Heart J       Date:  2015-12-05       Impact factor: 29.983

3.  Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus.

Authors:  Benjamin G Feakins; Emily C McFadden; Andrew J Farmer; Richard J Stevens
Journal:  Diagn Progn Res       Date:  2018-07-23

4.  Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT.

Authors:  Robert P Giugliano; Baris Gencer; Stephen D Wiviott; Jeong-Gun Park; Charles S Fuchs; Wolfram Goessling; Thomas A Musliner; Andrew M Tershakovec; Michael A Blazing; Robert Califf; Christopher P Cannon; Eugene Braunwald
Journal:  JACC CardioOncol       Date:  2020-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.